Dioxane-Linked Novel Bacterial Topoisomerase Inhibitors Exhibit Bactericidal Activity against Planktonic and Biofilm Staphylococcus aureus In Vitro
Open Access
- 21 December 2022
- journal article
- research article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 10 (6) , e0205622
Abstract
The pathogen Staphylococcus aureus contributes substantially to infection-related mortality. Biofilms render bacteria more recalcitrant to antibacterial therapy. The manuscript describes the potent activity of a new class of antibacterial agents against both planktonic and biofilm populations of Staphylococcus aureus .Keywords
Funding Information
- HHS | National Institutes of Health (R21 AI148986)
- HHS | National Institutes of Health (R01 AI134895)
- Dr. Ralph and Marian Falk Medical Research Trust (Transformational Award)
- Chih-Ming and Jane Chen Graduate Fellowship Fund in Medicinal Chemistry and Pharmacognosy (No number)
- Sick Kids Foundation (6610100082)
- Start-Up Funds (No number)
This publication has 43 references indexed in Scilit:
- New approaches for treating staphylococcal biofilm infectionsAnnals of the New York Academy of Sciences, 2011
- Review: Staphylococcus aureus and MRSA in cystic fibrosisJournal of Cystic Fibrosis, 2011
- Oritavancin Disrupts Membrane Integrity of Staphylococcus aureus and Vancomycin-Resistant Enterococci To Effect Rapid Bacterial KillingAntimicrobial Agents and Chemotherapy, 2010
- Oritavancin Kills Stationary-Phase and BiofilmStaphylococcus aureusCells In VitroAntimicrobial Agents and Chemotherapy, 2009
- Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 2008
- In Vitro Time-kill Activities of Rifalazil, Alone and in Combination with Vancomycin, against Logarithmic and Stationary Cultures of Staphylococcus aureusThe Journal of Antibiotics, 2006
- Clinical Relevance of Bacteriostatic versus Bactericidal Mechanisms of Action in the Treatment of Gram‐Positive Bacterial InfectionsClinical Infectious Diseases, 2004
- Synergy, antagonism, and what the chequerboard puts between themJournal of Antimicrobial Chemotherapy, 2003
- Contributions of Antibiotic Penetration, Oxygen Limitation, and Low Metabolic Activity to Tolerance of Pseudomonas aeruginosa Biofilms to Ciprofloxacin and TobramycinAntimicrobial Agents and Chemotherapy, 2003
- Riddle of Biofilm ResistanceAntimicrobial Agents and Chemotherapy, 2001